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Abstract
MicroRNAs (miRNAs) are small fragments of single-stranded RNA containing 18-24 nucleotides, and are generated from
endogenous transcripts. MicroRNAs function in post-transcriptional gene silencing by targeting the 39-untranslated region
(UTR) of mRNAs, resulting in translational repression. We have developed a system to study the role of miRNAs in cell
differentiation. We have found that one of the miRNAs tested in our system (miR-378, also called miR-378*) plays a role in
modulating nephronectin-mediated differentiation in the osteoblastic cell line, MC3T3-E1. Nephronectin is an extracellular
matrix protein, and we have demonstrated that its over-expression enhanced osteoblast differentiation and bone nodule
formation. Furthermore, we found that the nephronectin 39-untranslated region (39UTR) contains a binding site for miR-378.
Stable transfection of MC3T3-E1 cells with miR-378 inhibited cell differentiation. MC3T3-E1 cells stably transfected with
nephronectin exhibited higher rates of differentiation and nodule formation as compared with cells transfected with
nephronectin containing the 39UTR in the early stages of development, suggesting that endogenous miR-378 is present and
active. However, in the later stages of MC3T3-E1 development, the differentiation rates were opposite, with higher rates of
differentiation and nodule formation in the cells over-expressing the 39UTR of nephronectin. This appeared to be the
consequence of competition between nephronectin and UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalac-
tosaminyltransferase 7 (GalNAc-T7 or GalNT7) for miR-378 binding, resulting in increased GalNT7 activity, which in turn lead
to increased nephronectin glycosylation and product secretion, thereby resulting in a higher rate of osteoblast
differentiation.
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Introduction
Over the past few years, microRNAs (miRNAs) have emerged
as a prominent class of gene regulatory factors [1]. MiRNAs are
single-stranded RNAs of 18–24 nucleotides in length, and are
generated from endogenous transcripts producing hairpin struc-
tures by an RNase III-type enzyme [2–5]. miRNA functions as a
regulator in gene silencing by partially complementing with the 39-
untranslated region (39UTR) of target mRNAs, leading to
translational repression [6–8]. By silencing various target mRNAs,
miRNAs have key roles in various regulatory pathways. This
involves cell proliferation [9,10], division [11,12], apoptosis
[13,14], cell differentiation [15–20], tissue development [21–27],
tumor formation [28–43], protein expression [44–46], immuno-
response [47], and viral infection [48–51]. Although miRNAs
have emerged as key regulators of gene expression, our
understanding of the specific roles of miRNAs has been limited
due to the difficulty in tracking the functions of a particular
miRNA. Furthermore, since chemically synthetic miRNAs are
easily degraded, it is impossible to obtain stable cell lines
expressing miRNAs for long-term functional analysis in vitro
and in vivo. Although expression of a large DNA fragment has
made stable expression possible [52], in many cases miRNAs are
expressed as a cluster, making it difficult to distinguish the function
of a particular miRNA from others. To allow long-term studies of
miRNA functions in vitro and in vivo, we have developed an
expression vector expressing two copies of pre-miRNAs, a green
fluorescent protein (GFP) tracking unit, and an antibiotic selection
marker [53,54]. This allows stable expression of double amounts of
the miRNA of interest in cells for functional studies.
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7535Nephronectin was discovered in the developing mouse kidney as
a novel ligand for the integrin a8b1. It is a 70–90 kDa secreted
extracellular matrix protein that contains a putative signal peptide
at the N-terminus, five epidermal growth factor (EGF)-like repeats
(amino acids 57–250), an RGD sequence (amino acids 382–384),
and a C-terminal MAM domain (amino acids 417–561). As
nephronectin is expressed in a variety of tissues in the developing
mouse embryo, we studied the role of nephronectin in bone
development. We also examined the regulation of nephronectin
expression by miR-378 and demonstrated that miR-378 up-
regulated nephronectin expression, and enhanced nephronectin
glycosylation and secretion via binding to the 39UTR of
nephronectin mRNA. Interaction of miR-378 with nephronectin
39UTR arrested this miRNA and freed another miR-378 target
GalNT7, an enzyme essential for nephronectin glycosylation. As a
consequence, nephronectin glycosylation was enhanced and
osteoblast differentiation was promoted.
Results
Nephronectin promotes osteoblast differentiation
To study the role of nephronectin during osteoblast develop-
ment, we generated a nephronectin construct (Npnt). A leading
peptide (LP) of chicken link protein was tagged at the N-terminal
region, which contains the secretion signal and an epitope
recognized by the monoclonal antibody 4B6 (Fig. 1A). The
osteoblast cell line MC3T3-E1 was stably transfected with the
nephronectin construct or an empty vector. Conditioned medium
from each stable cell line was examined for expression and
secretion of nephronectin by western blot using the 4B6 antibody
Figure 1. Alkaline phosphatase expression in MC3T3-E1 cells over-expressing nephronectin. (A) A full-length nephronectin construct
was generated containing the 5 EGF-like repeats, RGD domain, and the MAM domain. A leading peptide (LP) was tagged at the N-terminal region of
the construct (Panel A). (B) After transfection, conditioned medium from two nephronectin- and one vector-transfected MC3T3-E1 clones was
analyzed for stable expression and secretion of the full-length nephronectin protein by western blot, using the monoclonal antibody 4B6 which
recognizes an epitope in the leading peptide. (C) Two nephronectin- and two vector-transfected MC3T3-E1 clones were grown for 10 days and
stained for ALP expression. Multiple fields were examined for each construct, and stained cells were counted per field for a quantitative graphical
representation. Over-expressing nephronectin (Npnt-1 and Npnt-2) enhanced ALP expression. (D) Typical micrographs of ALP expression in the two
clones were taken using two different phases (top and bottom panels) of the microscope for better estimation of ALP activity. (E) Left, MC3T3-E1 cells
stably transfected with an siRNA construct against nephronectin were grown in parallel with cells transfected with the empty vector for 10 days and
then stained for ALP activity. Multiple fields were examined for each construct, and stained cells were counted per field for quantitative analysis. Inset
shows the expression level of the nephronectin protein after transfection with the siRNA against nephronectin. Right, typical micrographs of ALP
expression are shown.
doi:10.1371/journal.pone.0007535.g001
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well known marker of commitment to the osteoblast lineage, in the
nephronectin-transfected MC3T3-E1 cells and observed a signif-
icantly higher level of ALP expression in the cells over-expressing
nephronectin as compared with the vector-transfected cells
(Fig. 1C). Typical micrographs are provided to show cell
morphology after staining (ALP activity seen as the red colour in
the wells, Fig. 1D, upper panel). Using a different phase on the
microscope, we could focus on only the cells exhibiting ALP
activity due to their red staining (Fig. 1D, lower panel). This
allowed quantification of the stained cells. Our results indicated
that over-expression of nephronectin promotes osteoblast
differentiation.
To determine the effect of endogenous nephronectin on
MC3T3-E1 cell differentiation, we analyzed the effect of knocking
down nephronectin expression on osteoblast differentiation. Cell
lines stably transfected with a small interfering RNA (siRNA)
plasmid targeting nephronectin (Npnt-siRNA), or with the GFP
vector alone, were generated. The GFP- and Npnt-siRNA-
expressing cells were cultured under nodule-inducing conditions
and then stained for ALP expression to identify differentiating
cells. We observed minimal ALP expression in the MC3T3-E1
cells over-expressing the siRNA as compared with the vector
control (Fig. 1E). Our results indicated that down-regulation of
endogenous nephronectin expression inhibited osteoblast
differentiation.
The effect of nephronectin 39UTR on osteoblast
differentiation
We then studied regulation of nephronectin expression by
miRNAs, as miRNAs have been reported to play essential roles in
cell differentiation. We generated a nephronectin expression
construct with a fragment of the nephronectin 39UTR (Fig. 2A,
Npnt+39). MC3T3-E1 cells were transfected with the construct
Npnt+39 to generate stable cell lines. Conditioned medium was
examined for expression and secretion of the ectopic nephronectin
by western blot (Fig. 2A). MC3T3-E1 cells transfected with either
the Npnt construct, the Npnt+39 construct, or the GFP vector
control were cultured for 6 days under nodule-inducing condi-
tions, followed by staining for ALP activity to identify differenti-
ating osteoblasts. Again, over-expression of nephronectin promot-
ed osteoblast differentiation as seen by the significantly higher ALP
staining as compared with the control cells (Fig. 2B and C). A
much lower rate of osteoblast differentiation was observed in the
cells expressing the Npnt+39 construct (Npnt+39-1 and Npnt+39-
2), thereby providing further evidence towards the post-transcrip-
tional repression of nephronectin by endogenous miRNAs during
osteoblast differentiation.
We then investigated the effect of over-expressing the 39UTR of
nephronectin over the full course of osteoblast development,
including mineralization and nodule formation. The transfected
cells were grown in parallel in nodule inducing conditions (regular
growth medium supplemented with ascorbic acid, beta-glycero-
phosphate, and dexamethasone) over the three phases of bone
development (proliferation, differentiation, and mineralization/
nodule formation). ALP expression and nodule formation were
analyzed on different days over the full course of osteogenesis.
Consistent with the above results, the Npnt-transfected cells
showed a significantly higher rate of differentiation as compared
with the vector controls (Fig. 3A). The Npnt+39-transfected cells
exhibited a lower rate of differentiation than the Npnt-transfected
cells during the early stages of osteogenesis until day 13. The rates
of differentiation became similar between the Npnt- and Npnt+39-
transfected cells by day 17, and finally, during the later stages of
osteogenesis (after day 27) the Npnt+39-transfected cells displayed
much higher levels of ALP activity than the Npnt-transfected cells.
Photographs of the whole wells are provided in Supplementary
(Fig. S1A). Statistical analysis indicated that all differences were
significant (Fig. 3B).
Once we observed nodule formation, the cells were stained with
silver nitrate for visualization of bone nodules. Multiple nodules
were first seen in the nephronectin-transfected cells on day 52 after
plating, indicating that the faster and greater rates of differenti-
ation in these cells led to faster and more pronounced nodule
formation as compared with the controls. The Npnt+39-transfect-
ed cells exhibited mineralization with minimal nodule formation
on day 52 (Fig. 3C). Interestingly, although the Npnt+39-
transfected cells exhibited delayed nodule formation compared
with the nephronectin-transfected cells, by day 56, the Npnt+39-
transfected cells exhibited fully formed nodules in a significantly
higher density than the nephronectin-transfected cells (Fig. 3D,
upper panel, Fig. S1B). By day 60, the Npnt+39 plates were almost
fully filled with bone nodules (Fig. 3D, lower panel).
The effect of 39UTR on nephronectin glycosylation
We then investigated whether or not the increase in differen-
tiation and nodule formation seen in the Npnt+39-transfected cells
was associated with nephronectin production. Npnt- and Npnt+39-
transfected cell lines were cultured in parallel under nodule
inducing conditions. One set of cells was lysed and the protein was
extracted after 48 hours (just before confluence), while the other
set was lysed for protein extraction after 10 days. Both sets were
analyzed for nephronectin levels by western blot. Forty-eight hours
after induction, the level of glycosylated nephronectin was found to
be much lower than the level of core protein in the Npnt-
transfected cells, while the Npnt+39-transfected cells containing
the 39UTR showed much greater levels of glycosylated protein
than core protein (Fig. 4A). Ten days after induction, the level of
secreted glycosylated protein was significantly greater in the
Npnt+39-transfected cells.
It has been predicted that a high degree of glycosylation occurs
in the region of nephronectin containing the MAM domain [55].
Therefore, to confirm glycosylation of nephronectin, a truncated
nephronectin construct was generated containing only the MAM
domain. MC3T3-E1 cells were transfected separately with either
the construct containing only the MAM domain or the full-length
nephronectin. The conditioned medium obtained from the MAM
and the Npnt-transfected cells was dialyzed and subjected to
treatments with PNGase F, sialidase, O-glycanase, and a mix of
sialidase and O-glycanase. A reduction in molecular size was
obtained with PNGase F treatment, and treatment with a mix of
sialidase and O-glycanase (Fig. 4B). De-glycosylation of nephro-
nectin by various enzymes indicated its potential N- and O-
glycosylation. The major band shift by co-treatment with sialidase
and O-glycanase suggested its glycoform as sialic acid-capped O-
glycosylation.
Effect of miR-378 on osteoblast differentiation
The above results indicate that the 39UTR of nephronectin
played a role in modulating nephronectin-mediated osteoblast
differentiation. We then searched for potential miRNAs that might
regulate nephronectin functioning. Multiple computational ap-
proaches were used to analyze the 39UTR of nephronectin mRNA
for miRNA binding sites/sequences. The miRNA that was
predicted to be of great potential for nephronectin binding was
miR-378. MiR-378 base pairs well with the 39UTR of nephro-
nectin from nucleotides 1893–1913 and 1903–1923 (Fig. 5A), and
was therefore selected for further analyses as a putative regulator
miR-378 in Differentiation
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endogenous miR-378 was examined in MC3T3-E1 osteoblasts
under differentiation-inducing conditions. The experiments indi-
cated that miR-378 expression increased significantly during cell
condensation at around day 10, followed by a sharp decline during
cell differentiation (Fig. 5B), suggesting involvement of miR-378 in
MC3T3-E1 cell differentiation.
To study the role of miR-378 in MC3T3-E1 differentiation, it is
essential to ectopically provide the cells with miR-378 constantly.
Current methods use chemically synthetic miRNAs for functional
studies, which could only last for a few days before degradation.
Since nephronectin-mediated MC3T3-E1 cell differentiation takes
place at least one week after induction, it is essential to obtain
stable cell lines expressing miR-378. We thus developed a method
to generate a construct that stably expresses miR-378. The
construct contained a H1 promoter driving expression of pre-miR-
378, an antibiotic selection marker, and a GFP for monitoring
transfection efficiency [53]. Transient transfection of U87 cells
with this construct indicated high efficiency of GFP expression.
Using two primers, miR-378N (59agatctagggctcctgactcc) and miR-
378C (59aggccttctgactccaagtcc), which amplify the exogenously
transfected miR-378 but not endogenous miR-378, we observed
Figure 2. The effect of nephronectin 39UTR on osteoblast differentiation. (A) A nephronectin construct with a fragment of the nephronectin
39UTR spanning the target sequence of miR-378 is shown (Npnt+39). Cell lysate and conditioned medium from MC3T3-E1 cells stably transfected with
Npnt+39 were analyzed by western blot showing secretion of the product. (B) Cells transfected with the full-length nephronectin (Npnt-1 and Npnt-
2), nephronectin containing the 39UTR (Npnt+39-1 and Npnt+39-2), or with the control vector were grown for 10 days and stained for ALP expression.
Multiple fields were examined for each construct, and stained cells were counted per field for quantitative analysis. (C) Typical micrographs of ALP
expression are shown using two different phases (top and bottom panels) of the microscope.
doi:10.1371/journal.pone.0007535.g002
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was processed to produce mature miR-378 as expected (data not
shown). This expression system has been successfully used in our
previous studies [53,54].
MC3T3-E1 cells were stably transfected with the miR-378
construct or a control vector expressing GFP alone. Two sets of
clones were cultured in parallel under nodule-inducing conditions.
The cells were cultured for 6 days and then stained for the
expression of ALP to identify differentiating cells. We observed
minimal ALP expression in the MC3T3-E1 cells over-expressing
miR-378 as compared with the two empty vector-transfected cell
lines. Typical photographs are shown (Fig. 5C, right). Using a
different phase on the same microscope, only the cells stained for
ALP were visualized and counted for quantification of ALP
expression (Fig. 5C, left). Based on the significant difference in
ALP expression between MC3T3-E1 cells transfected with the
empty vector and those expressing miR-378, our results indicate
that over-expression of miR-378 inhibits osteoblast differentiation.
Up regulation of nephronectin expression by miR-378
It has been known that miRNAs repress mRNA translation by
targeting the 39UTR. We performed experiments to test whether
co-transfection of Npnt+39 with miR-378 would reduce ectopic
nephronectin expression. Unexpectedly, we not only detected an
Figure 3. Nephronectin 39UTR promotes nodule formation. (A) Time course analysis showing the different effects of Npnt and Npnt+39
transfection on MC3T3-E1 differentiation: early stages, Npnt.Npnt+39; late stages, Npnt,Npnt+39. (B) Multiple fields were examined for each
construct, and stained cells were counted per field for quantitative analysis. (C) The cell lines were cultured under nodule-inducing conditions over
the three different phases of osteoblast development. Magnified images of bone nodules formed on days 52 and 56 are shown after silver nitrate
staining for the detection of bone nodules. (D) Photographs of the whole plates showing bone nodules on day 60 are shown in the lower panel. The
total number of bone nodules was statistically analyzed and have been represented in the upper panel. ** p,0.01.
doi:10.1371/journal.pone.0007535.g003
miR-378 in Differentiation
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observed an increased level of nephronectin core protein in
MC3T3-E1 osteoblasts stably transfected with Npnt+39 and miR-
378 (Fig. 6A). This result was then confirmed using multiple
transient and stable transfections of HEK293 cells (data not
shown).
To better understand the increase in nephronectin production
by miR-378 expression, we performed differentiation experiments
in the same combination as those performed in the western blot
analyses. Upon miR-378 transfection, differentiation in nephro-
nectin-transfected cells was inhibited in a similar manner as in the
mock-transfected cells (Fig. 6B). Co-expression of miR-378 with
Npnt+39 significantly promoted cell differentiation, consistent with
enhanced nephronectin synthesis, glycosylation, and product
secretion. The Npnt+39-transfected cells not only induced a
greater number of cells to undergo differentiation, but also
produced stronger ALP staining seen by the red color (Fig. 6C). To
corroborate these results, we carried out proliferation experiments
on the MC3T3-E1 cells stably co-transfected with miR-378/GFP
and nephronection/Npnt+39. The experiments showed that co-
transfection of miR-378 and nephronectin increased cell prolifer-
ation (Fig. S1C), while co-transfection of miR-378 and Npnt+39
inhibited cell proliferation (Fig. S1D) as compared with the control
groups.
To test the significance of the putative binding sites on
nephronectin expression, we generated mutations on both binding
sites to disrupt the base pairing structures between miR-378 and
nephronectin 39UTR (Fig. 7A). PCR assays were used to test the
potential interactions as previously described [56]. Mature miR-
378 was used as a primer in the PCR paring with another primer
located in the vector. A plasmid (39UTR) containing a small
fragment of Npnt coding sequence and the 39UTR and a plasmid
(39UTR-mu) containing the mutation as shown in Fig. Fig. 7A
served as PCR-templates (Fig. 7B). PCR product was produced
with 39UTR as a template but could not be detected with 39UTR-
mu as a template (Fig. 7C). Cells were also transfected with
nephronectin containing the 39UTR (Npnt+39) or the mutant
39UTR (Npnt+39-mu). Expression of the mutant construct
Figure 4. The 39UTR of nephronectin promoted nephronectin
protein glycosylation. (A) Cell lysate from the two MC3T3-E1 stable
cells lines (over-expressing the nephronectin protein with and without
the 39UTR) was prepared from 48 hour cultures and 10 day cultures.
The lysate and conditioned medium was analyzed on western blot
probed with the 4B6 antibody. The bands representing glycosylated
nephronectin and the nephronectin core protein have been marked
separately. (B) Conditioned medium was treated with different de-
glycosylation enzymes to reduce the observed molecular size in
western blot to confirm nephronectin glycosylation. The cells trans-
fected with either the full-length nephronectin or just the MAM domain
possessed potential O-glycosylation, which accounts for the significant
size-difference in Fig. 4A. Filled arrows indicate the de-O-glycosylated
product; and open arrows show the size of core protein.
doi:10.1371/journal.pone.0007535.g004
Figure 5. Targeting of nephronectin with miR-378. (A) Compu-
tational algorithms were used to predict the miRNA that binds to a
target sequence in the 39-UTR of nephronectin. miR-378 was found to
have the strongest binding to the 39UTR of nephronectin from
nucleotides 1902–1923. (B) Expression of endogenous miR-378 in
MC3T3-E1 cells under differentiation-inducing conditions was measured
by real-time PCR. (C) Left, MC3T3-E1 cells stably transfected with the
miR-378 construct were grown in parallel with cells transfected with the
control vector for 10 days and stained for ALP activity. Multiple fields
were examined for each construct, and stained cells were counted per
field for quantitative analysis. Right, typical micrographs of ALP
expression are shown in two separate stable clones.
doi:10.1371/journal.pone.0007535.g005
miR-378 in Differentiation
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product (Fig. 7D), suggesting that the miR-378 binding sites are
important for the upregulation of nephronectin production and
secretion.
The 39UTR of nephronectin modulates miR-378 targeting
GalNT7
The initial delay and later increase in the onset of differentiation
and nodule formation seen in the Npnt+39-transfected cells as
compared with the nephronectin-transfected cells suggests that the
nephronectin 39UTR is significant in osteoblast differentiation. We
then examined protein expression affected by the 39UTR. HEK293
cells stably transfected with nephronectin or nephronectin contain-
ing the 39UTR were harvested and subjected to proteomic analysis
performed by WEMB Biochem Inc (Richmond Hill, ON). A large
number of proteins were altered (Table S1). Interestingly,
expression of UDP-N-acetyl-alpha-D-galactosamine:polypeptide
N-acetylgalactosaminyltransferase 7 (GalNT7), an enzyme known
to glycosylate proteins, in the Npnt+39-transfected cells increased to
5.3-fold as compared with nephronectin-transfected cells [fold
change=(reading
Npnt+39 – reading
nephronectin)/reading
nephronectin]
(Fig. 8A).
Figure 6. Effect of miR-378 and 39UTR on nephronectin expression, and its biological activity in double-transfected cells. (A) Western
blot for Npnt expression in the double-transfected cells. miR-378 elevated Npnt expression only when 39UTR was present. Both glycosylated and core
protein bands were observed. (B) Cell differentiation as revealed by ALP staining for Npnt-transfected and Npnt+39-transfected cells. miR-378
expression inhibited differentiation in Npnt- and mock-transfected cells. However, miR-378 promoted osteoblast differentiation extensively in
Npnt+39-transfected cells, implying that miR-378 interacted with the 39UTR and exerted its effect. (C) Typical results in Panel B are provided showing
that the presence of the 39UTR promoted cell differentiation upon miR-378 transfection.
doi:10.1371/journal.pone.0007535.g006
miR-378 in Differentiation
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approaches and identified a putative binding site for miR-378 at
GalNT7 (Fig. 8B). The GalNT7 39UTR containing the miR-378
target site was inserted into the luciferase reporter vector producing
a construct named luc-Gal-UTR (Fig. S2A). The miR-378 target
site was mutated producing a mutant construct named luc-Gal-mut.
Luciferase activity assays were performed to confirm the targeting.
U343 cells were co-transfected with miR-378 and luc-Gal-UTR or
luc-Gal-mut. Figure 8C shows that miR-378 significantly decreased
luciferase activity in luc-Gal-UTR-transfected cells, but did not
affect luciferase activity in the luc-Gal-mut-transfected cells,
indicating targeting of GalNT7 39UTR by miR-378.
To confirm the down-regulation of GalNT7 by miR-378, cell
lysate was prepared from the cells transfected with miR-378 or
GFP and analysed by western blot. Repression of GalNT7 was
detected in the cells transfected with miR-378 as compared with
the cells transfected with GFP (Fig. 8D). U87 cells transfected with
GFP (Fig. 8E) or miR-378 (Fig. 8F) were subjected to
immunocytometry probed with anti-GalNT7 antibody, followed
by confocal microscopic examination. MiR-378-transfected cells
expressed lower levels of GalNT7 than the GFP-transfected cells.
These results were also confirmed in MT-1 cell line (Fig. S2B).
On the other hand, we transfected MC3T3 cells, which express
high level of endogenous miR-378 as demonstrated above, with
anti-miR-378 expression construct or a control vector. Cell lysates
were prepared and analyzed on western blot probed with anti-
GalNT7 antibody. The experiments showed that GalNT7
expression was promoted by anti-miR-378 transfection (Fig. 8G),
suggesting that miR-378 is sufficient in regulating GalNT7
expression. Furthermore, we transfected MC3T3 cells with
siRNAs against GalNT7 designed and synthesized by Gene-
Pharma (Shanghai). We found that all four siRNAs significantly
silenced GalNT7 expression (Fig. S2C). The effects of these
siRNAs on nephronectin post-translational modification and
secretion were tested by co-transfecting the MC3T3 cells with
one of these four siRNA or an RNA oligo of random sequence
with nephronectin expression construct. We found that co-
transfection with the siRNAs against GalNT7 produced lower
levels of nephronectin in the culture medium as compared with the
transfection using the RNA oligo with random sequence (Fig. 8H,
arrow), suggesting decreased secretion of nephronectin product.
Since glycosaminoglycan of a core protein by modifying enzymes
is essential for proteoglycan secretion [57–59], these results
confirm that GalNT7 plays a role in nephronectin synthesis. We
Figure 7. Mutation of the miR-378 binding sites inhibits nephronectin glycosylation. (A) Mutation was generated in the 39UTR of Npnt+39
construct as shown (Npnt+39-mu, upper panel). This impaired both putative binding sites for miR-378 (bottom). (B) Strategy of PCR showing
interaction of miR-378 with Npnt 39UTR, which was abolished by sited-directed mutagenesis. (C) Typical PCR products are shown using the mature
miR-378 as a primer for the PCR (arrow). The lower bands were primers used for the PCR assays. (D) Cell lysate prepared from cells transfected with
Npnt+39 and the mutant Npnt+39-mu was analyzed with western blot showing decreased expression of the mutant construct.
doi:10.1371/journal.pone.0007535.g007
miR-378 in Differentiation
PLoS ONE | www.plosone.org 8 October 2009 | Volume 4 | Issue 10 | e7535Figure 8. Targeting of O-glycosyltransferase, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase
7 (GalNT7) by miR-378. (A) U87 cells transfected with Npnt or Npnt+39 were harvested and subjected to proteomic analysis. Up-regulation of
GalNT7 expression was seen in cells transfected with Npnt+39. (B) Computational algorithms were used to predict potential targeting of miR-378 on
GalNT7. miR-378 was found to possesses a potential target site on GalNT7 in nucleotides 3360-3378. A fragment of the GalNT7 39UTR harbouring the
miR-378 target site was inserted into a luciferase reporter vector. The seed region for miR-378 binding was mutated in GalNT7 as shown (red). (C)
Luciferase activity assays were performed by co-transfection of miR-378 with luciferase reporter constructs. Decreased luciferase activity was detected
in the construct containing GalNT7 39UTR, which was abolished when the miR-378 target site was mutated. (n=4, ** p,0.01). (D) Western blot
showing decreased expression of GalNT7 in miR-378-transfected cells compared with GFP-transfected cells. (E-F) U87 cells stably transfected with GFP
(E) or miR-378 (F) were immunostained with anti-GalNT7 antibody, followed by confocal microscopic visualization. While both types of cells expressed
GFP (green), miR-378-transfected cells expressed lower levels of GalNT7 than the GFP-transfected cells (red). As a result, the merged color of miR-378-
transfected cells were less yellow. (G) MC3T3 cells were transfected with anti-miR-378 or a control vector at 3 or 6 mg plasmids. Cell lysates were
prepared and analyzed on western blot probed with anti-GalNT7 antibody. Transfection with anti-miR-378 enhanced GalNT7 expression. (H) MC3T3
cells were co-transfected with nephronectin and one of the four siRNA oligos against GalNT7 or an oligo at random sequence serving as a negative
control. Culture medium was analyzed on western blot probed with the monoclonal antibody 4B6 that recognizes nephronectin. Transfection with
siRNAs against GalNT7 decreased the levels of secreted nephronectin.
doi:10.1371/journal.pone.0007535.g008
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by siRNA expression, suggesting that GalNT7 is not involved in
the modification of this band.
We reasoned that over-expressing the 39UTR-containing
nephronectin mRNA resulted in greater binding capacity of
nephronectin 39UTR to miR-378 and lesser concentrations than
usual of free miR-378 that would be available for targeting and
binding to GalNT7. This would free more GalNT7 mRNA and
up-regulate GalNT7 protein levels for enhancing glycosylation of
nephronectin. As a consequence, due to more than usual
glycosylation of the core protein, secretion of nephronectin
product would be promoted. To test this, competition assays were
performed. The luciferase reporter vector containing the 39UTR
of GalNT7 was co-transfected with Npnt+39 or Npnt+39-mu.
Analysis of luciferase activities indicated that luc-Gal-UTR
expressed greater activities when co-transfected with Npnt+39
than when co-transfected with Npnt+39-mu (Fig. 9A). As shown in
the diagram (Fig. 9B), Npnt 39UTR was able to bind miR-378 and
free GalNT7 39UTR. As a result, luc-Gal-UTR activities
increased. On the other hand, Npnt 39UTR-mu could no longer
bind miR-378, nor up-regulate luc-Gal-UTR activities.
To confirm these results, we prepared cell lysate from cells
transfected with nephronectin or Npnt+39 and subjected them to
western blot analysis, probing them with anti-GalNT7 antibody
(Abnova, Taipei). The results indicated that cells transfected with
Npnt+39 expressed higher levels of GalNT7 than cells transfected
with nephronectin (Fig. 9C). The experiments concluded that the
presence of nephronectin 39UTR arrested miR-378 and freed
GalNT7 mRNA for GalNT7 protein expression.
Discussion
The clonal osteoblastic cell line MC3T3-E1 that is derived from
newborn mouse calvaria has been used extensively as an in vitro
model system for studying bone development. These cells undergo
an orderly, time-dependent developmental sequence over three
stages that are analogous to the respective stages of in vivo bone
development. Nephronectin is an extracellular matrix protein
known to be highly expressed in the long bone. This study was
initiated by examination of the role of nephronectin in osteoblast
differentiation and we discovered that ectopic expression of
nephronectin promoted osteoblast differentiation. In the in vitro
model system for bone development, ALP activity was used as a
marker for osteoblast differentiation. Only the differentiated
osteoblasts would stain pink/red for ALP expression. There was
a significant difference in ALP expression between MC3T3-E1
cells transfected with the empty vector and those expressing full-
length nephronectin. The function of endogenous nephronectin
was confirmed by knocking down nephronectin expression with
the siRNA approach.
We then investigated the mechanisms that could be involved in
the regulation of nephronectin-mediated action. MiRNAs are
known to bind to the 39UTRs of genes to regulate their expression
post-transcriptionally. Since nephronectin bears a long 39UTR, we
hypothesized that nephronectin expression is regulated by
miRNAs. To test this hypothesis, we engineered a fragment of
the nephronectin 39UTR into the nephronectin expression
construct. As expected, MC3T3-E1 cells stably transfected with
nephronectin bearing the 39UTR fragment (Npnt+39) differenti-
ated in lower levels as compared with those transfected with
nephronectin alone in the early stages of differentiation. These
results suggested that some endogenous miRNAs might have
interacted with the 39UTR fragment and repressed nephronectin
expression resulting in a lower level of osteoblast differentiation.
Nevertheless, Npnt+39-transfected cells still differentiated at higher
levels than the mock-transfected cells suggesting incomplete
repression of ectopically transfected nephronectin. Unexpectedly,
on examining the Npnt+39-transfected cells over the three stages of
bone development, we observed that the initial delay in osteoblast
differentiation was followed by an equal rate of differentiation, that
finally resulted in the Npnt+39-transfected cells exhibiting
significantly higher levels of osteoblast differentiation. This pattern
Figure 9. Npnt 39UTR competes with GalNT7 39UTR for miR-378
binding. (A) U343 cells were transiently transfected with luciferase
reporter vector harboring the GalNT7 39UTR (lu-Gal-UTR) and different
constructs at the amounts indicated on the figure (ng). Luciferase
activities were normalized using the control as 100%. The luciferase
activities were higher when co-transfected with Npnt+39 as compared
with Npnt+39-mu, suggesting that increased supplies of Npnt+39
absorbed some endogenous miRNAs freeing luciferase translation. (B)
Diagram showing competition of Npnt+39, but not Npnt+39-mu, with
GalNT7 for miR-378 binding. As a result, luc-Gal-UTR was freed from
miR-378 binding and thereby having higher luciferase activities. (C)
Western blot showing increased expression of GalNT7 in the Npnt+39-
transfected cells compared with the Npnt-transfected cells.
doi:10.1371/journal.pone.0007535.g009
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in bone nodule formation, the Npnt+39-transfected cells produced
significantly higher densities of bone nodules than the nephro-
nectin-transfected cells.
We hypothesized that over-expression of the 39UTR might have
attracted certain miRNAs binding to this fragment and, thereby
making them unavailable for targeting some glycosylation-
associated enzymes, which are essential for glycosylation of
nephronectin. This in turn would increase the activity of
glycosylation-associated enzymes, leading to produce more
glycosylated nephronectin. Consequently, more nephronectin is
secreted to promote osteoblast differentiation. To test this
hypothesis, we investigated the differences in glycosylation of the
nephronectin core protein in the presence and absence of the
nephronectin 39UTR using the two stable cell lines transfected
with nephronectin or Npnt+39. Western blot analysis showed that
the Npnt+39-transfected cells had a much higher level of
glycosylated nephronectin compared with the nephronectin-
transfected cells. These results therefore support our hypothesis.
The post-transcriptional regulation of nephronectin by miRNA
was then examined. The use of bioinformatics algorithms showed
that the 39UTR of nephronectin was a potential target of miRNA
miR-378. To examine the effect of miR-378, we generated a
construct expressing dual fragments of pre-miR-378. Stable over-
expression of the miR-378 construct strongly inhibited MC3T3-
E1 differentiation. We have previously demonstrated that miR-
378 enhances cell survival and tumor growth [53]. The report
presented here that miR-378 inhibits cell differentiation is in
consistent with our previous finding.
To examine the probability that translation of nephronectin was
repressed by miR-378, we performed a number of co-transfection
experiments including transient transfection and stable transfec-
tion of Npnt+39 with the miR-378 construct in MC3T3-E1
osteoblasts and Hek293 cells. Unexpectedly, co-transfection of
Npnt+39 with miR-378 not only promoted nephronectin glyco-
sylation, but also enhanced production of nephronectin, perhaps
through enhanced translation, while miR-378 showed little effect
on nephronectin (no 39UTR) expression, as expected. We could
explain this phenomenon by the fact that nephronectin might not
be a true target of miR-378 although the sequence in its 39UTR
matches well with the sequence of miR-378. The ability to reliably
identify the targets of a given miRNA has been known to be a
major problem in the miRNA field. Most of the computational
predictions of miRNA targets focus on base pairing between the
miRNA ‘‘seed’’ region and its target mRNA. Despite the presence
of the same target sites, it remains unclear why miR-378 was able
to repress luciferase activity while the nephronectin 39UTR when
placed in the luciferase construct was not able to repress
nephronectin expression. Zhao and co-workers have presented
evidence for target selectivity which depends on the free energy
surrounding the target site [60]. They proposed that a stable
environment with lower free energy may not be accessible to the
miRNA silencing complex as compared with the one with higher
free energy (or unstable environment). We have also found that the
secondary structure of the common miRNA binding site and its
flanking regions is normally located in an unstable region with a
multi-branching loop-like RNA structure [8]. How the average
free energy flanking regions in a miRNA binding site affect
targeting by a particular miRNA as well as the efficiencies of
miRNA repression of gene expression await further investigation.
Bearing this in mind, we propose that binding of miR-378 to the
39UTR of nephronectin not only did not exert direct repression of
nephronectin synthesis, but it also created a secondary structure
which is less accessible to other miRNAs which normally target
nephronectin and regulate its expression. This space hindrance
resulted in increased synthesis of nephronectin. Furthermore, the
binding interaction of miR-378 with nephronectin 39UTR would
reduce free miR-378 for targeting nephronectin glycosylation-
associated enzyme(s). As a consequence, the enzyme(s) expression
would be enhanced resulting in increased nephronectin glycosyl-
ation and product secretion. We have previously demonstrated
that glycosylation is an essential step for product secretion [57–59].
Concurrent with increased nephronectin protein synthesis,
glycosylation, and secretion was the inhibition of proliferation
and promotion of differentiation in MC3T3-E1 cells that were co-
transfected with miR-378 and the Npnt+39 construct.
To test whether some glycosylation-associated enzymes were
affected, total proteins in MC3T3-E1 cells stably transfected with
nephronectin or Npnt+39 were subjected to proteomic and
computational analyses. Indeed, GalNT7, an enzyme known to
glycosylate proteins, was up-regulated in Npnt+39-transfected cells
and was downregulated by miR-378 expression. These results
explained why expression of nephronectin 39UTR was able to
promote MC3T3-E1 differentiation and bone nodule formation in
the late stages. However, it is not clear why these phenomena were
not seen in the early stages. It is possible that the over-expressed
nephronectin, although not secreted due to lack of glycosylation,
interfered with some signalling molecules inside the cells, playing a
role in cell differentiation. This awaits further investigation.
Taken together, we have reported a mechanism by which a
miRNA can function in promoting protein expression in two ways.
It can be achieved by binding to the 39UTR and resulting in space
hindrance preventing easy access of other miRNAs, thereby
protecting the mRNA from being regulated post-transcriptionally.
Secondly, a miRNA can promote protein expression by binding to
the 39UTR and freeing the true target of the miRNA, thereby
increasing the levels of the target, which in turn enhances protein
modification and secretion.
Materials and Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM), alpha modified
Eagle’s medium (AMEM), fetal bovine serum (FBS), trypsin/
EDTA, Lipofectamine 2000, geneticin (G418), hygromycin were
purchased from Wisent Inc. T4 DNA ligase, platinum Pfx DNA
polymerase, SuperScript II reverse transcriptase, DH5a, and tissue
culture supplies were purchased from Invitrogen. Restriction
enzymes were purchased from New England Biolabs. RedTaq
DNA polymerase, anti-actin and HRP-conjugated secondary
antibodies, de-glycosylation enzymes (PNGase F, O-glycosidase,
sialidase, and keratanase), horseradish peroxidase-conjugated goat
anti-mouse IgG secondary antibody, and other general chemicals
were purchased from Sigma. Tissue culture plates were purchased
from Sarstedt (Montreal, QC, Canada). ECL Western blot
detection kit was from Amersham Life Science (Baie d’Urfe ´,
QC, Canada). The MC3T3-E1 cell line was obtained from the
American Type Culture Collection (Rockville, MD).
Cell culture
MC3T3-E1 and Hek293 cells were maintained in alpha-MEM
and DMEM, respectively, supplemented with 10 (v/v) % fetal
bovine serum,100 units/ml penicillin, and 100 mg/ml streptomycin.
Plasmid transfection was done using Lipofectamine 2000 according
to the manufacturer’s instruction. Transfected cells were selected
under growth medium with 1 mg/ml G418 and were stable for
more than one month before experiments.
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for 2 weeks. In brief, 10
4 cells were seeded on 12-well plates. The
cells were harvested at indicated time points by trypsin/EDTA
and then resuspended in 1 ml culture medium. After centrifuga-
tion, cell pellets were resuspended in 1% FBS containing 70%
ethanol and kept at 4uC until analysis. Prior to use, the cell
suspensions were exchanged into 1 ml fetal bovine serum (PBS)
and the cell number was counted with a flow cytometer
(FACSCalibur, BD bioscience, NJ, USA).
Differentiation of MC3T3-E1 osteoblast cells was carried out by
incubation in differentiation medium (50 mg/ml ascorbic acid,
10 mM beta-glycerophosphate, and 10
28 M dexamethasone in
alpha-MEM). The medium was changed every 2–3 days. Cell
differentiation was identified by ALP staining. In general,
differentiated cell layers were washed with PBS and fixed with
neutral formalin (10% formaldehyde in PBS) for 15 min. After
removal of fixation solution and successive incubation in distilled
water for 15 min, the cell layers were stained with a staining
solution (1 mg/ml Naphthol AS-MX-PO4; 6 mg/ml fast red
violet LB salt, in 10 mM Tris-HCl, pH 8.0) at 37uC for 45 min.
After removal of staining solution and rinsing 3 times with water,
the stained cells were kept in distilled water for microscopic
examination.
Construct generation
The nephronectin cDNA was a kind gift of Dr. Louis. F.
Reichardt. The primer sets used to amplify the two constructs of
nephronectin are as follows. Npnt-N (59cccgggctcgagtggcccagg-
caaatagtttct) and Npnt-C (59cccgggtctagatcagcagcgacctcttttcaa)
were used to clone nephronectin coding sequence. Npnt-N and
Npnt-end (59cccgggtctagaaggaaattccatgcccaccct) were used to
clone nephronectin coding sequence plus the 39UTR. MAM-N
(59cccgggctcgaggtgtatatccccaaagtc) and Npnt-C were used to
cloned the fragment containing the MAM domain. A link protein
leading peptide (LP) was attached to the N-terminus of the
construct to allow product secretion and detection by the
monoclonal antibody 4B6 [61,62]. The sequences of the generated
constructs were confirmed by restriction digestion and sequencing.
A luciferase reporter vector (pMir-Report; Ambion) was used to
generate luciferase constructs containing either GalNT7 39UTR
or mutant GalNT7 39UTR. The 39UTR of GalNT7 was cloned
using two primers, GalNT7-SacI (59cccggggagctcgcccttgttagat-
taggccttata) and GalNT7-MluI (59gggcccacgcgtcatttgcaatattt
ggttttcctaa), by PCR. The PCR products were then digested with
SacI and MluI and the fragment was inserted into a SacI- and
MluI-digested pMir-Report Luciferase plasmid (Ambion), to
obtain a luciferase construct, luc-Gal-UTR. The mutant construct
was generated with two primers, GalNT7-SacI and GalNT7-
MluI-mut (59gggcccacgcgtcatttgcaatatttggttt
—––
aggaaatagg) using the
same method.
To generate a small interfering RNA against nephronectin, two
primers (59ccaggtagatctaggactgaactgtgtgtatattcaagagtatacacacagtt-
cagtccgactgccgaccagcagagcag and 59gggctaaagcttaaaaaacagtac-
cactacacgagtagagaacattactcgtgtagtggtactgctgctctgctggtcggcagtc)
were designed for PCR. The PCR product was digested with BglII
and HindIII and inserted into the BglII- and HindIII-digested
BluGFP vector [53], resulting in a construct expressing siRNA
against nephronectin.
The construct for miR-378 was designed by us and synthesized
by Top Gene Technologies (Montreal, Canada). In brief, the pre-
miRNA of miR-378 was ligated into the mammalian expression
vector BluGFP that contains a Bluescript backbone, a CMV
promoter driving the GFP, and a promoter driving the expression
of miR-378 as previous described [53,63].
Western blot and proteomic analysis
For western blot analysis, cells were harvested by 10 mM
EDTA at 60–80 % confluence and washed three times with PBS
using centrifugation. The cells (1610
6 cells) were disrupted and
kept on ice for 15 min. The lysate was then centrifuged at
maximum speed using a desktop centrifuge at 4 degrees for
10 min. Protein concentrations were quantified by a protein assay
kit (Bio-Rad Laboratories Ltd., ON, Canada). Protein lysate (100
mg) was subjected to SDS-polyacrylamide gel electrophoresis
(PAGE) and the separated proteins were transferred onto a
nitrocellulose membrane followed by blocking and incubation in a
primary monoclonal antibody overnight at 4 degrees. After
washing, the membrane was incubated with HRP-conjugated
goat-anti-mouse secondary antibody for 1 hour at room temper-
ature followed by ECL detection.
For proteomic analysis, the cells were cultured for three days
under normal growth conditions. The cells were detached from
the culture dishes by 1 mM EDTA and then washed three times
with PBS. Cell pellets were then delivered on dry ice for proteomic
analysis by WEMB Biochem Inc (Richmond Hill, ON, Canada).
Characterization of protein glycosylation
To characterize the type of post-translational modification of
nephronectin, the conditioned medium containing fully glycosy-
lated nephronectin was digested by different de-glycosylation
enzymes. The size of the resulting protein was then observed by
western blot. The conditioned medium (30 ul) was treated with 10
ml enzyme solution containing 2 units PNGase F (to release N-
glycan), 2.5 units O-glycosidase (to release O-glycan), 0.01 units
sialidase (to release terminal sialic acid) or 0.1 units keratinase (to
release keratin sulfate) at 37uC overnight. To completely remove
the O-glycan from the protein core, the combined digestion by O-
glycosidase and sialidase was achieved by the same incubation
conditions.
Statistical Analysis
The results (mean values6SD) of all experiments were subjected
to statistical analysis by the t-test. The level of significance was set
at P,0.05.
Supporting Information
Figure S1 Effects of nephronectin on MC3T3-E1 cell activities.
(A) Time course analysis showing the different effects of Npnt and
Npnt+39 transfections on MC3T3-E1 differentiation: early stages,
Npnt.Npnt+39; late stages, Npnt,Npnt+39. (B) The cell lines
were cultured under nodule-inducing conditions over the three
different phases of osteoblast development. Bone nodules formed
on day 56 are shown after silver nitrate staining for the detection of
bone nodules. The existence of miR-378 slightly enhanced cell
proliferation in Npnt-transfected cells (C), but inhibited cell
proliferation in Npnt+39-transfected cells (D).
Found at: doi:10.1371/journal.pone.0007535.s001 (1.52 MB PPT)
Figure S2 Targeting of GalNT7 by miR-378. (A) A fragment of
GalNT7 39UTR was inserted into the luciferase report vector
pMir-Report producing a construct named luc-Gal-UTR. The
potential miR-378 target sequence was labelled in blue. Mutations
labelled in red color were generated in the miR-378 target
sequence producing a mutant construct named luc-Gal-mut. (B)
MT-1 cells stably transfected with GFP and miR-378 were
immunostained with anti-GalNT7 antibody, followed by confocal
microscopic analysis. While both types of cells expressed GFP
(green), miR-378-transfected cells expressed lower levels of
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merged color of miR-378-transfected cells were less yellow. (C)
MC3T3 cells were transiently transfected with siRNAs or a
random sequence serving as a negative control. Silencing of
GalNT7 expression were analyzed by real-time PCR.
Found at: doi:10.1371/journal.pone.0007535.s002 (2.35 MB PPT)
Table S1
Found at: doi:10.1371/journal.pone.0007535.s003 (3.79 MB PPT)
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